Related Experiment Videos
A stable binary complex between Leishmania major thymidylate synthase and the substrate deoxyuridylate. A
The Journal of Biological Chemistry
|July 5, 1987
Summary
Deoxyuridylate (dUMP) binds slowly to Leishmania major thymidylate synthase-dihydrofolate reductase (TS-DHFR) forming an isolable complex. This dUMP-TS complex is catalytically inactive and does not inhibit enzyme activity, suggesting a unique binding mechanism.
Area of Science:
- Biochemistry
- Parasitology
- Enzymology
Background:
- Thymidylate synthase (TS) activity in Leishmania major is crucial for DNA synthesis and is part of a bifunctional TS-dihydrofolate reductase (TS-DHFR) enzyme.
- Understanding nucleotide binding to TS-DHFR is essential for developing targeted anti-parasitic therapies.
Purpose of the Study:
- To investigate the binding kinetics and characteristics of deoxyuridylate (dUMP) with Leishmania major TS-DHFR.
- To elucidate the nature of the binary complex formed between dUMP and TS-DHFR and its implications for enzyme activity.
Main Methods:
- Isolation of binary enzyme-nucleotide complexes using Sephadex G-25 chromatography and nitrocellulose filter binding.
- Kinetic analysis of dUMP binding to TS-DHFR.
- Competition experiments using inhibitors and products like 5-fluorodeoxyuridylate (FdUMP) and deoxythymidylate (dTMP).
Main Results:
- A slow-binding mechanism for dUMP to TS-DHFR was identified, forming an isolable binary complex with a dissociation constant of approximately 0.1 microM.
- The stoichiometry of binding was determined to be 1 mol dUMP per mol of dimeric TS-DHFR.
- Competition studies confirmed that dUMP, FdUMP, and dTMP bind to the same active site on the enzyme.
- The preformed dUMP-TS complex was found to be catalytically incompetent and did not inhibit enzyme activity, despite slow dUMP dissociation.
Conclusions:
- dUMP binds to a catalytically incompetent site on one subunit of the dimeric TS-DHFR.
- This binding does not affect the activity of the other enzyme subunit.
- The findings suggest a non-canonical substrate binding mechanism that may have implications for drug development against Leishmania parasites.